(GST-fusion protein) and pRSET-A (His 6 fusion proteins). Mammalian expression vector for CaMKKα was generated by amplifying the coding region of rat CaM-KKα isoform by PCR from pME18SCaMKKα wt by using primers: rCam-KK U EcoRI (5-ggaattcggagcgcagtccagccg-3) and rCam-KK D Asp718I (5-ccggtacctcaggatgcagcctcatcttc-3). The PCR product was digested with EcoRI-Asp718I, purified by gel electrophoresis, and subcloned into the ClaI-Asp718I site of expression plasmid pCAGGS (31) with ClaI-EcoRI fragment from pCSMT (32) to generate pCAGGS Myc-CaMKKα.
Glutathione S-Transferase (GST) Fusion Protein Expression, Pulldown and In Vitro Binding Assays
GST-CaMKKα, GST-14-3-3, and His 6 -14-3-3γ and τ constructs were expressed and purified as previously described (33) . For pulldown assays, 1 to 4 µg of GST fusion protein was loaded on glutathione sepharose. When indicated, GST-CaMKKα was phosphorylated in vitro with PKA (1 µg/ml) and ATP for 20 minutes at 32 o C. The PKA phosphorylation reaction was stopped by addition of 2 µM PKI and washing with 4-fold excess volume of lysis buffer. For pulldown experiments, rat brain cytosol (with addition of 0.5% Triton-X-100) was added to the immobilized GST-CaMKK and incubated with rocking at 4 o C for 2 to 4 hours. To remove unbound proteins, the beads were washed 2 to 3 times with lysis buffer followed by SDS-PAGE. Bound 14-3-3 was detected by immunoblotting with pan-14-3-3 antibodies.
Cell Culture and Transfection
HEK293 and COS7 cells were cultured as previously described (14) . 
Acute Hippocampal Slice Preparation
Adult male Sprague Dawley rats (6-8 weeks old) were anesthetized with pentobarbital (60mg/kg I.P.) and sacrificed by decapitation. The brains were removed within one minute of decapitation and immediately submerged in ice-cold, oxygenated (95% O 2 /5%
CO 2 ) sucrose-ACSF for hippocampal dissection (in mM): sucrose 110, NaCl 60, KCl 2.5, NaHCO 3 28, NaH 3 PO 4 1.25, CaCl 2 0.5, MgCl 2 7, glucose 5, sodium ascorbate 0.6, pH 7.4 at 4 o C. Hippocampal slices (400 µm, transverse) were prepared in ice-cold sucrose-ACSF using a vibratome and transferred as cut to warm, oxygenated ACSF (in mM: NaCl 125, KCl 2.5, NaHCO 3 21.4, NaH 3 PO 4 1.25, CaCl 2 2, MgCl 2 1, glucose 11.1, pH 7.4 at 32 o C) for recovery (30 min 37 o C, then the chamber was equilibrated for 1.5 -2 hrs at 22 o C). Slices from the dorsal and ventral thirds of the hippocampus were discarded. Following recovery, slices were transferred to ACSF at 32 o C and equilibrated for one hour, pre-treated with H89, 11-R PKI peptide or 11-R Control peptide and then treated with or without 25 µM Forskolin for 5 minutes. Slices were kept submerged at all times. Post-stimulation, the slices were immediately lysed by homogenization in 1%
Triton-X-100 in a glass dounce homogenizer. The lysates were cleared by ultracentrifugation (100,000 g, 30 mins.) and cleared lysates used for immunoprecipitation as described.
Immunoprecipitation and Immunoblotting
For immunoprecipitation, rat forebrain, acute hippocampal slices, hippocampal cultures or transfected heterologous cells were lysed in Lysis Buffer (1% Triton-X-100, 137 mM NaCl, 50 mM HEPES pH 7.4, 5 mM EGTA pH 7.4, 5 mM EDTA pH7.4, 20 mM NaF, 20 mM NaPPi, 1 mM β-glycerol phosphate, protease inhibitors (leupeptin, aprotinin, antipain, PMSF, Pepstatin A) and microcystin (1 µM). with the Odyssey near Infrared Imaging Platfom System (LI-COR) and data captured using the Odyssey scanner. For quantification of data, the X-ray film based western blot data were scanned and densititzed using Kodak Imaging Software and the data gathered using the Odyssey system was densitized with the same system software. All the data were further processed and normalized using Microsoft Excel and statistical analyses performed using Prism software.
Kinase activity Assay
Immobilized GST-CaMKKα was incubated with kinase buffer (50 mM HEPES pH 7.4, 10 mM MgCl 2 , 0.4 mM ATP and protease inhibitors) and PBS for mock phosphorylation or with PKA (1 µg/0.5 ml) at 32 o C for 10 to 20 minutes. Reaction was stopped with the addition of 1 µM PKI. The samples were then either extracted with SDS-sample buffer and processed for SDS-PAGE or used for phosphatase assay.
Phosphatase Assay
For PP1 and PP2A, reactions were done in a buffer consisting of 50 mM HEPES pH 7. Figure 2A ). However, this triple mutant construct of GSTCaMKKα still robustly interacted with 14-3-3 ( Figure 2B , middle panel). In fact, the triple mutant exhibits stronger interaction and pulls down additional 14-3-3 isoforms (lower band). Perhaps elimination of these PKA phosphorylation sites enhances the phosphorylation stoichiometry of the critical site(s) required for 14-3-3 binding (see below).
To identify the 14-3-3 interaction site in CaMKK, two GST constructs were made, one "canonical" 14-3-3 sequence.
14-3-3 isoform selectivity for CaMKK interaction
To further our understanding of the functional consequence of the CaMKKα interaction with 14-3-3, we investigated whether CaMKKα preferentially binds to any specific 14-3-3 isoform(s) (36) . COS7 cells were mock-or transiently-transfected with Myc-epitope tagged expression vectors of 14-3-3 isoforms. CaMKKα preferentially bound to 14-3-3 η and γ isoforms from these lysates ( Figure 3A , left panel, lanes 5-8), whereas the ε and ζ isoforms did not bind ( Figure 3A , left panel, lanes 1,2 and lanes 9,10 respectively). Similar myc-14-3-3 expression levels were observed in the lysates ( Figure 3A , right panel).
To further examine this isoform selectivity, we expressed and purified recombinant GST-tagged 14-3-3 ε, η, γ, τ and ζ proteins. The GST-14-3-3 proteins were immobilized on glutathione-Sepharose and used for pull-down assays with 1% Triton-X-100 rat brain extract as the source of native CaMKK. Rat brain CaMKK was pulled down with highest efficiency by 14-3-3γ ( Figure 
CaMKK and 14-3-3 co-precipitate from brain
We have demonstrated a strong interaction between CaMKKα and 14-3-3 in vitro using GST pull-down assays. However, for this interaction to have physiological relevance, we needed to confirm the existence of this protein complex in cells. When CaMKKα was transiently transfected in COS7 cells, we observed co-immunoprecipitation of endogenous 14-
3-3 with transfected CaMKK (data not shown). Furthermore, when FLAG-tagged CaMKKα or
CaMKKβ were expressed in HEK293 cells and affinity purified, interaction with 14-3-3 was detected by mass spectroscopy (T. Saneyoshi and T. Natsume, unpublished observation) as described (38) .
Because CaMKK and 14-3-3γ are highly expressed in brain, we tested whether endogenous CaMKKα interacts with native 14-3-3 in rat forebrain extracts. CaMKK co- shown).
14-3-3 interaction regulates catalytic activity of CaMKK
Having established that CaMKK interacts with protein 14-3-3 in neurons, it was
important to determine what functions of CaMKK might be regulated by 14-3-3. Interactions of other proteins with 14-3-3 have been shown to regulate their subcellular localization (cytoplasmic vs. nuclear partition), catalytic function, or perturb protein-protein interactions (19, 35, 40) . Thus, several possibilities exist for the functional regulation of CaMKK by 14-3-3.
Although the primary motif for 14-3-3 interaction with CaMKK , Ser 74 , is somewhat Nterminal to the catalytic domain of CaMKKα ( Fig. 2A) , we examined whether 14-3-3 binding might affect the catalytic activity of CaMKKα using a pull-down kinase assay. GST-CaMKK was immobilized on glutathione-Sepharose without or with PKA phosphorylation. The GSTCaMKK was then incubated without or with His 6 -14-3-3γ or His 6 -14-3-3τ. Since 14-3-3τ
did not interact with CaMKKα in previous experiments, this served as a control for 14-3-3γ.
The complex of 14-3-3 bound to GST-CaMKK was washed to remove excess, unbound 14-3-3. This complex of CaMKK without or with bound 14-3-3 was used to test the activity of CaMKKα. A well-established downstream target of CaMKK is Thr 177 in the activation loop of CaMKI (3). We used purified recombinant, catalytically-inactive (to prevent autophosphorylation) CaMKI as a substrate for testing the activity of CaMKK, and phosphorylation of Thr 177 was detected using a phospho-specific antibody for this site (8, 17) .
CaMKK strongly phosphorylated CaMKI ( Figure 5A , left panel, upper blot, lanes 1,2), and this was not altered by addition of 14-3-3γ in the absence of PKA phosphorylation (lanes 3-5),
indicating there were no non-specific effects of 14-3-3 on the kinase assay. When wild-type
CaMKK was phosphorylated by PKA, we observe a strong inhibition of CaMKK catalytic activity in the absence of 14-3-3γ (pd0.001). Figure 5A , left panel, upper blot, lanes 6-8 and bar graph). This inhibitory effect of PKA phosphorylation on CaMKK is previously described and is a result of phosphorylation of Thr 108 and Ser 458 (14, 15) . When 14-3-3γ binds PKAphosphorylated CaMKK, we observed an additional small but significant inhibition of catalytic activity (pd0.01) ( Figure 5A , left panel, upper blot, lanes 9-11, and bar graph). This inhibition of CaMKK activity is specific for binding of 14-3-3γ to CaMKK since the addition 14-3-3τ, an isoform that does not bind CaMKK, did not show a significant further decrease in catalytic activity. The levels of CaMKI phosphorylation were reflective of CaMKK catalytic activity since all assays had equivalent amounts of CaMKI and CaMKK ( Figure 5A , left panel, middle and lower blots respectively). All the immunoblot data was densitized and normalized as (phospho-CaMKI/total CaMKI)/total CaMKK. The mean of the normalized data for CaMKK activity in absence of PKA phosphorylation and 14-3-3 was given a relative value of 100, and the rest of the data set were normalized to this. These data suggest that interaction of 14-3-3 with phospho-CaMKK can further depress its activity.
Because PKA phosphorylation of Thr 108 and Ser 458 strongly suppress CaMKK activity, it was difficult to examine the inhibitory effect of 14-3-3γ binding to phopho-Ser 74 . To obviate this problem, we used the double mutant Thr108Gly and Ser458Ala. With this CaMKK mutant, PKA cannot phosphorylate and inhibit CaMKK via Thr 108 and Ser 458 but will still phosphorylate Ser 74 and result in 14-3-3 binding (Fig. 2B ). This should allow us to specifically test the inhibitory effect of 14-3-3 interaction with CaMKK as these mutations have little effect on the activity of CaMKKα. As expected, PKA phosphorylation of this mutant CaMKK had no affect on its catalytic activity ( Figure 5B , left panel, upper blot, lanes 6-8, and bar graph).
However, addition of 14-3-3γ, but not 14-3-3τ, to this PKA-phosphorylated CaMKK mutant resulted in about 60% inhibition of CaMKK catalytic activity ( Figure 5B , left panel, upper blot, lanes 9-11). These data with the T108G/S458A CaMKKα construct demonstrate that interaction with 14-3-3γ has the potential to significantly inhibit CaMKK catalytic activity.
14-3-3 blocks dephosphorylation of Thr 108 by Protein Phosphatase 2A
Since interaction of 14-3-3 with Ser 74 , either through steric or conformational effects, can alter the activity of CaMKK, we tested whether this interaction might also regulate dephosphorylation of CaMKK. We determined that a commercial "anti-PKA" site phosphospecific antibody detects PKA phosphorylation of CaMKK only at Thr 108 . As shown in Fig. 6A , this phospho-specific antibody recognizes PKA-phosphorylated wild-type CaMKK as well as the mutants Ser74Ala and Ser458Ala but not Thr108Gly. Thus, we used this anti-PKA phospho-Ser/Thr antibody to specifically assess levels of Thr 108 phosphorylation in CaMKK and whether interaction of 14-3-3 blocks dephosphorylation of this inhibitory site by protein phosphatases.
Initial studies showed that PP2B exhibited poor dephosphorylation of Thr 108 under our experimental conditions (data not shown), so it was not further examined. Because 14-3-3 has been reported to interact with the catalytic subunits of both PP1 and PP2A (22), we tested whether 14-3-3 directly inhibited either phosphatase using p-nitrophenylphosphate as substrate.
The presence of 14-3-3γ (0.2 µg/µl) gave slight (10-15%) inhibition of both phosphatases in this assay (data not shown). With PKA-phosphorylated CaMKK as substrate, PP2A gave robust dephosphorylation of Thr108, and this dephosphorylation was completely blocked by the presence of 14-3-3 (Fig. 6B) . To confirm that the protection from dephosphorylation of Thr 108
by PP2A was indeed mediated by 14-3-3γ binding to Ser 74 , we repeated the same experiment except for use of the Ser74Ala mutant that cannot bind 14-3-3. With the Ser74Ala mutant, 14-3-3 had no effect on dephosphorylation of Thr 108 , confirming that the effect of 14-3-3 was due to its binding to CaMKK. Although PP1 also gave strong dephosphorylation of Thr 108 in CaMKK, the suppression of dephosphorylation by 14-3-3 was observed with both wild-type and Ser74Ala mutant (data not shown), making interpretation of the results difficult. These data indicate that 14-3-3γ plays a prominent role in inhibiting CaMKK activity, both by active inhibition of catalysis and also by prolonged maintenance of phosphorylation of the neighboring inhibitory site, Thr 108 .
Protection by 14-3-3γ of phospho-Thr 108 by 14-3-3 from dephosphorylation in HEK293
cells.
To investigate whether 14-3-3 protects against dephosphorylation of phospho-Thr 108
CaMKK in intact cells, we transiently co-transfected HEK293 cells with myc-tagged CaMKK plus either pcDNA3.1 (empty vector) or flag-tagged 14-3-3γ. Twenty-four to thirty-six hours post-transfection the cells were pre-incubated with either vehicle (DMSO) or the phosphatase inhibitors okadaic acid (OA) or cyclosporine A for 30 minutes at 37 o C, then treated with 20µM
Forskolin for 10 minutes to stimulate PKA-mediated phosphorylation of CaMKK. Transfected
CaMKK was immunoprecipitated using anti-myc antibody, and the phosphorylation state of Thr 108 was determined by western blotting with anti-PKA phospho-S/T antibody (described above).
In the absence of transfected 14-3-3γ, Forskolin produced a 4-to 5-fold increase in phosphorylation of Thr 108 . Treatment by cyclosporine A (CsA), a selective and potent membrane-permeable inhibitor of PP2B (41), had no effect on the phosphorylation status of Thr 108 ( Figure 7A , left panel, lane 3), suggesting that PP2B is relatively inactive towards Thr 108 under these conditions. Okadaic acid (42), a potent inhibitor of PP2A that can also block PP1, resulted in a dramatic increase in Forskolin-stimulated phosphorylation of Thr 108 ( Figure 7A , left blot, lanes 4) due to inhibition of PP2A and perhaps PP1.
We have shown in vitro that interaction of 14-3-3γ prevents dephosphorylation of Thr 108 (Fig. 6B) . If this regulation occurs in cells, co-transfection with 14-3-3γ should mimic the effect of okadaic acid to enhance Thr 108 phosphorylation. In congruence with this hypothesis, co-transfection with 14-3-3γ increased Thr 108 phosphorylation after Forskolin stimulation to a level equivalent to that observed by okadaic acid treatment ( Figure 7A , right panel, lanes 1-4).
These data demonstrate that 14-3-3γ regulates the phosphorylation state of Thr 108 in intact cells. Although our studies focused on the α-isoform of CaMKK, it appears that 14-3-3 also interacts with the β↑isoform of CaMKK since they co-immunoprecipitated when over-expressed in COS or HEK293 cells (data not shown). Functional consequences of the interaction of CaMKK with 14-3-3. As mentioned in the Introduction, interaction of 14-3-3 with its various target proteins can have multiple functional consequences. The 14-3-3 dimer is a rigid structure that can act as an "allosteric clamp" to modify enzyme conformation and activity (44) in response to a signaling pathway that phosphorylates the "gatekeeper" site. According to this hypothesis there is a primary "gatekeeper" phosphorylation site (e.g., Ser 74 ) necessary for initial binding of one of the 14-3-3 subunits. Once bound, the second subunit of the 14-3-3 dimer can interact with a secondary site in the target protein, thereby producing an "allosteric clamp" in the target protein. This secondary site can be another phospho-Ser/Thr (26).
Discussion

Dynamic regulation of
In the specific case of CaMKK, binding of 14-3-3 inhibits kinase activity through two mechanisms. The first is direct inhibition of CaMKK activity. This is most clearly seen using the T108G/S458A mutant that is not directly inhibited by PKA phosphorylation of these two Thus, one might predict that elevation of Ca 2+ prior to PKA activation may blunt the inhibition of CaMKK by PKA. Therefore, it is difficult to predict the cellular consequences of inhibition of CaMKK by PKA, and future experiments specifically designed to explore these issues will be necessary to understand the physiological impact of this cross-talk. Cell supernatants were applied to PKA-phosphorylated GST-CaMKK immobilized beads for 3 hours at 4 o C followed by washing. Bound 14-3-3 was detected by immunoblotting with anti-myc antibody (left panel), and 3% of lysate was blotted to determine expression levels (right panel). B. GST fusions of the indicated 14-3-3 isoforms were used in pull-down assays with a 1% Triton-X-100 rat brain extract as the source of CaMKK. experiments. In each set of results, the +PKA and -phosphatase result was set at 100%
and rest of the data were normalized to this. 
